NCT02149043

Brief Summary

Ulcerative colitis represents a chronic condition occurring in relapsing and remitting fashion with uncertain outcome and requires lifelong treatment with considerable side effects. Diagnostic methods currently in use, clinical (endoscopy), imaging (CT, MR) or laboratory (C - reactive protein, fecal calprotectin) give an insight into disease activity but are possibly associated with significant discomfort for the patient and / or increased risk of irradiation and potential allergic reactions on contrast agents. For that reason there is a need for a noninvasive, biologically inert method for evaluation of disease activity in inflammatory bowel disease (IBD). Thermography possesses most of these characteristics. The aim of this study is to find potential link between pathological thermographic signs and endoscopic findings, serum C reactive protein (CRP) and calprotectin in the stool of patients with active and extensive ulcerative colitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2014

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 29, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

July 17, 2018

Status Verified

July 1, 2018

Enrollment Period

3 years

First QC Date

May 20, 2014

Last Update Submit

July 13, 2018

Conditions

Keywords

Inflammatory bowel diseaseUlcerative ColitisThermographyEndoscopyCRPFecal Calprotectin

Outcome Measures

Primary Outcomes (1)

  • Change in abdominal surface temperatures in ulcerative colitis patients at 6 months

    Patients will be treated with mesalamin, corticosteroids or biologic therapy according to disease status during 6 months. Abdominal temperatures (maximal, minimum and average temperatures measured in Celsius) recorded by a thermographic camera will be acquired at enrollment and after 6 months of therapy.

    Six months

Secondary Outcomes (5)

  • Correlation of abdominal surface temperatures between ulcerative colitis patients and healthy volunteers.

    Baseline and after 6 months

  • Correlation of abdominal surface temperature values with clinical markers of inflammation in ulcerative colitis.

    Baseline and after 6 months

  • Correlation of abdominal surface temperature values with fecal markers of inflammation in ulcerative colitis.

    Baseline and after 6 months

  • Correlation of abdominal surface temperature values with serum markers of inflammation in ulcerative colitis.

    Baseline and after 6 months

  • Correlation of abdominal surface temperature values with endoscopic markers of inflammation in ulcerative colitis.

    Baseline and after 6 months

Study Arms (2)

Ulcerative Colitis patients

30 patients with active ulcerative colitis will be put throe thermography and colonoscopy. Their stool will be tested for fecal calprotectin and their blood for CRP and other laboratory measures.

Device: ThermographyProcedure: Colonoscopy

Healthy volunteers

30 healthy individuals matching sex and BMI to those of ulcerative colitis patients will be put throe thermography and have their stool tested for fecal calprotectin and their blood for CRP.

Device: Thermography

Interventions

Thermographic imaging of the patient's abdomen surface

Healthy volunteersUlcerative Colitis patients
ColonoscopyPROCEDURE

Endoscopic examination of the colon

Ulcerative Colitis patients

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be recruited among active ulcerative colitis patients hospitalized in University Hospital Dubrava. Healthy individuals matching sex and BMI to those of recruited ulcerative colitis patients.

You may qualify if:

  • Endoscopic diagnosis of active extensive ulcerative colitis
  • Stool Calprotectin \> 150 mcg/g
  • CRP \> 5 mg/L
  • Signed informed consent form

You may not qualify if:

  • Inability to preform total colonoscopy
  • Marked abdominal comorbidities
  • Prior abdominal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Dubrava

Zagreb, 10000, Croatia

Location

Related Publications (3)

  • Banić M, et al. Thermography in patients with inflammatory bowel disease and colorectal cancer: evidence and review of the method. Periodicum biologorum 113(4): 439-444, 2011.

    BACKGROUND
  • Božin, Tonći, et al.

    BACKGROUND
  • Banić, Marko, et al.

    BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Stool samples for fecal calprotectin concentration measurements.

MeSH Terms

Conditions

Colitis, UlcerativeInflammatory Bowel Diseases

Interventions

ThermographyColonoscopy

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisThermometryInvestigative TechniquesEndoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Marko Banić, MD, PhD

    University Hospital Dubrava

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Gastroenterology Resident

Study Record Dates

First Submitted

May 20, 2014

First Posted

May 29, 2014

Study Start

January 1, 2015

Primary Completion

January 1, 2018

Study Completion

June 1, 2018

Last Updated

July 17, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations